Skip to main content

Follicular Lymphoma News (Page 2)

FDA Approves Genentech’s Gazyva (obinutuzumab) for Certain People with Previously Treated Follicular Lymphoma

South San Francisco, CA – February 26, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Gazyva...

FDA Approves Zydelig (idelalisib) for CLL and Lymphoma

July 23, 2014 – The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers. Zydelig is being granted traditional approval to treat...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

Rituxan, clarithromycin, rituximab